Loss of p21(WAF1/CIP1) expression correlates with disease progression in gastric carcinoma

British Journal of Cancer

Volumn 75, Issue 11, 1997, Pages 1617-1620

  Ogawa, M ^a   Maeda, K ^a   Onoda, N ^a   Chung, Y S ^a   Sowa, M ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Disease progression; Gastric carcinoma; P21(WAF1 CIP1)

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER SURGERY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS;

EID: 0030610068     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.276     Document Type: Article

References (24)

1. Chen YQ, Cipriano SC, Arenkiel JM and Miller FR (1995) Tumor suppression by p2IWAF1. Cancer Res 55: 4536-4539
2. Constancia M, Seruca R, Carneiro F, Silva F and Castedo S (1994) Retinoblastoma gene structure and product expression in human gastric carcinomas. Br J Cancer 70: 1018-1024
3. Dulic V, Kaufmann WK, Wilson SJ, Tishy TD, Lees E, Harper JW, Elledge SJ and Reed SI (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibloblasts during radiation-induced GI arrest. Cell 76: 1013-1023
4. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parson R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1. a potential mediator of p53 tumor suppression. Cell 75: 817-825
5. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919
6. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW and O'Connnor PM (1994) p53 gene mutations associated with decreased sensitivity of human lymphoma cells to DNA-damaging agent. Cancer Res 54: 5824-5830
7. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donnell M and Hurwitz J (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 91: 8655-8659
8. Gabbert HE, Muller W, Schneiders A, Meier S and Hommel G (1995) The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 76: 720-726
9. Gao X, Chen YQ, Wu N, Grignon DJ, Sakr W, Porter AT and Honn KV (1995) Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. Oncogene 11: 1395-1398.
10. Harper JW, Adami GR, Wei N, Kayomarsl K and Elledge SJ (1993) The p21 Cdkinteracting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
11. Hawkins DS, Demers GW and Galloway DA (1996) Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 56: 892-898
12. Hermaking H, Funk JO, Reichert M, Ellwart JW and Eick D (1995) Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene 11: 1409-1415
13. Japanese Research Society for Gastric Cancer (1981) The general rules for gastric cancer study. Jpn J Surg 11: 127-139
14. Joypaul BV, Hopwood D, Newman EL, Qureshi S, Grant A, Ogston SA, Lane DP and Cuschieri A (1994) The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 69: 943-946
15. Jung JM, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA and Zhang W (1995) Increased level of p21 WAF1/Cip1 in human brain tumors. Oncogene 11: 2021-2028
16. Li R, Waga S, Hannon GJ, Beach D and Stillman B (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537
17. Maeda K, Chung YS, Onoda N, Kato Y, Nitta A, Arimoto Y, Yamada N, Kondo Y and Sowa M (1994) Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Cancer 73: 528-533
18. Maeda K, Chung YS, Takatuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y, Kondo Y and Sowa M (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13: 477-481
19. Martin HM, Filipe MI, Morris RW, Lane DP and Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50: 859-862
20. Noda A, Ning Y, Venable SF, Pereia-Smith OM and Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-98
21. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW (1993) Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53: 4776-4780
22. Tahara E (1995) Genetic alterations in human gastrointestinal cancers. Cancer Supplement 75: 1410-1417
23. Upadhway S, Li G, Liu H, Chen YQ, Sarkar FH and Kim HRC (1995) bel-2 suppresses expression of p21 WAF1/CIP1 in breast epithelial cells. Cancer Res 55: 4520-4524
24. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D (1993) P21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704